[1]
Hynes, R.O. The extracellular matrix, not just pretty fibrils. Science, 2009, 326(5957), 1216-1219.
[2]
Ma, M.Z.; Zhuang, C.; Yang, X.M.; Zhang, Z.Z.; Ma, H.; Zhang, W.M.; You, H.; Qin, W.; Gu, J.; Yang, S.; Cao, H.; Zhang, Z.G. CTHRC acts as a prognostic factor and promotes invasiveness of gastrointestinal stromal tumors by activating Wnt/PCP-Rho signaling. Neoplasia, 2014, 16(3), 265-278.
[3]
Ye, Q.H.; Qin, L.X.; Forgues, M.; He, P.; Kim, J.W.; Peng, A.C.; Simon, R.; Li, Y.; Robles, A.I.; Chen, Y.; Ma, Z.C.; Wu, Z.Q.; Ye, S.L.; Liu, Y.K.; Tang, Z.Y.; Wang, X.W. Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat. Med., 2003, 9(4), 416-423.
[4]
Bergamini, C.; Sgarra, C.; Trerotoli, P.; Lupo, L.; Azzariti, A.; Antonaci, S.; Giannelli, G. Laminin-5 stimulates hepatocellular carcinoma growth through a different function of alpha6beta4 and alpha3beta1 integrins. Hepatology, 2007, 46(6), 1801-1809.
[5]
Li, H.; Ge, C.; Zhao, F.; Yan, M.; Hu, C.; Jia, D.; Tian, H.; Zhu, M.; Chen, T.; Jiang, G.; Xie, H.; Cui, Y.; Gu, J.; Tu, H.; He, X.; Yao, M.; Liu, Y.; Li, J. Hypoxia-inducible factor 1 alpha-activated angiopoietin-like protein 4 contributes to tumor metastasis via vascular cell adhesion molecule-1/integrin β1 signaling in human hepatocellular carcinoma. Hepatology, 2011, 54(3), 910-919.
[6]
Muir, A.; Danai, L.V.; Vander Heiden, M.G. Microenvironmental regulation of cancer cell metabolism, implications for experimental design and translational studies. Dis. Model Mech., 2018, 11(8) , pii, dmm035758.
[7]
Camussi, G.; Deregibus, M.C.; Bruno, S.; Cantaluppi, V.; Biancone, L. Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int., 2010, 78(9), 838-848.
[8]
Hidai, C.; Zupancic, T.; Penta, K.; Mikhail, A.; Kawana, M.; Quertermous, E.E.; Aoka, Y.; Fukagawa, M.; Matsui, Y.; Platika, D.; Auerbach, R.; Hogan, B.L.; Snodgrass, R.; Quertermous, T. Cloning and characterization of developmental endothelial locus-1, an embryonic endothelial cell protein that binds the alphavbeta3 integrin receptor. Genes Dev., 1998, 12(1), 21-33.
[9]
Zhong, J.; Eliceiri, B.; Stupack, D.; Penta, K.; Sakamoto, G.; Quertermous, T.; Coleman, M.; Boudreau, N.; Varner, J.A. Neovascularization of ischemic tissues by gene delivery of the extracellular matrix protein Del-1. J. Clin. Invest., 2003, 112(1), 30-41.
[10]
Ho, H.K.; Jang, J.J.; Kaji, S.; Spektor, G.; Fong, A.; Yang, P.; Hu, B.S.; Schatzman, R.; Quertermous, T.; Cooke, J.P. Developmental endothelial locus-1 (Del-1), a novel angiogenic protein, its role in ischemia. Circulation, 2004, 109(10), 1314-1319.
[11]
Choi, E.Y.; Chavakis, E.; Czabanka, M.A.; Langer, H.F.; Fraemohs, L.; Economopoulou, M.; Kundu, R.K.; Orlandi, A.; Zheng, Y.Y.; Prieto, D.A.; Ballantyne, C.M.; Constant, S.L.; Aird, W.C.; Papayannopoulou, T.; Gahmberg, C.G.; Udey, M.C.; Vajkoczy, P.; Quertermous, T.; Dimmeler, S.; Weber, C.; Chavakis, T. Del-1, an endogenous leukocyte-endothelial adhesion inhibitor, limits inflammatory cell recruitment. Science, 2008, 322(5904), 1101-1104.
[12]
Sun, J.C.; Liang, X.T.; Pan, K.; Wang, H.; Zhao, J.J.; Li, J.J.; Ma, H.Q.; Chen, Y.B.; Xia, J.C. High expression level of EDIL3 in HCC predicts poor prognosis of HCC patients. World J. Gastroenterol., 2010, 16(36), 4611-4615.
[13]
Luo, J.H.; Ren, B.; Keryanov, S.; Tseng, G.C.; Rao, U.N.; Monga, S.P.; Strom, S.; Demetris, A.J.; Nalesnik, M.; Yu, Y.P. Ranganathan, S.; Michalopoulos, G.K. Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas. Hepatology, 2006, 44(4), 1012-1024.
[14]
Damhofer, H.; Medema, J.P.; Veenstra, V.L.; Badea, L.; Popescu, I.; Roelink, H.; Bijlsma, M.F. Assessment of the stromal contribution to Sonic Hedgehog-dependent pancreatic adenocarcinoma. Mol. Oncol., 2013, 7(6), 1031-1042.
[15]
Watanabe, T.; Kobunai, T.; Yamamoto, Y.; Ikeuchi, H.; Matsuda, K.; Ishihara, S.; Nozawa, K.; Iinuma, H.; Kanazawa, T.; Tanaka, T.; Yokoyama, T.; Konishi, T.; Eshima, K.; Ajioka, Y.; Hibi, T.; Watanabe, M.; Muto, T.; Nagawa, H. Predicting ulcerative colitis-associated colorectal cancer using reverse-transcription polymerase chain reaction analysis. Clin. Colorectal Cancer, 2011, 10(2), 134-141.
[16]
Beckham, C.J.; Olsen, J.; Yin, P.N.; Wu, C.H.; Ting, H.J.; Hagen, F.K.; Scosyrev, E.; Messing, E.M.; Lee, Y.F. Bladder cancer exosomes contain EDIL-3/Del1 and facilitate cancer progression. J. Urol., 2014, 192(2), 583-592.
[17]
Lee, J.E.; Moon, P.G.; Cho, Y.E.; Kim, Y.B.; Kim, I.S.; Park, H.; Baek, M.C. Identification of EDIL3 on extracellular vesicles involved in breast cancer cell invasion. J. Proteomics, 2016, 131, 17-28.
[18]
Jeong, D.; Ban, S.; Oh, S.; Jin Lee, S. Yong Park, S.; Koh, Y.W. Prognostic significance of EDIL3 expression and correlation with mesenchymal phenotype and microvessel density in lung adenocarcinoma. Sci. Rep., 2017, 7(1), 8649.
[19]
Yang, Z.F.; Poon, R.T. Vascular changes in hepatocellular carcinoma. Anat. Rec. (Hoboken), 2008, 291(6), 721-734.
[20]
Pang, R.; Poon, R.T. Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma. Cancer Lett., 2006, 242(2), 151-167.
[21]
Niu, J.X.; Zhang, W.J.; Ye, L.Y.; Wu, L.Q.; Zhu, G.J.; Yang, Z.H.; Grau, G.E.; Lou, J.N. The role of adhesion molecules, alpha v beta 3, alpha v beta 5 and their ligands in the tumor cell and endothelial cell adhesion. Eur. J. Cancer Prev., 2007, 16(6), 517-527.
[22]
Wang, Z.; Longaker, M.T.; Yang, G.P. Anti-apoptotic effects of the angiogenic factor Del1 on endothelial cells. J. Surg. Res., 2006, 130, 237.
[23]
Helpman, L.; Kupets, R.; Covens, A.; Saad, R.S.; Khalifa, M.A.; Ismiil, N.; Ghorab, Z.; Dubé, V.; Nofech-Mozes, S. Assessment of endometrial sampling as a predictor of final surgical pathology in endometrial cancer. Br. J. Cancer, 2014, 110(3), 609-615.
[24]
Greenwald, Z.R.; El-Zein, M.; Bouten, S.; Ensha, H.; Vazquez, F.L.; Franco, E.L. Mobile screening units for the early detection of cancer, a systematic review. Cancer Epidemiol. Biomarkers Prev., 2017, 26(12), 1679-1694.
[25]
Heitzer, E.; Perakis, S.; Geigl, J.B.; Speicher, M.R. The potential of liquid biopsies for the early detection of cancer. NPJ Precis. Oncol., 2017, 1(1), 36.
[26]
Wulfkuhle, J.D.; Liotta, L.A.; Petricoin, E.F. Proteomic applications for the early detection of cancer. Nat. Rev. Cancer, 2003, 3(4), 267-275.
[27]
Coultas, L.; Chawengsaksophak, K.; Rossant, J. Endothelial cells and VEGF in vascular development. Nature, 2005, 438(7070), 937-945.
[28]
Opławski, M.; Michalski, M.; Witek, A.; Michalski, B.; Zmarzły, N.; Jęda-Golonka, A.; Styblińska, M.; Gola, J.; Kasprzyk-Żyszczyńska, M.; Mazurek, U.; Plewka, A. Identification of a gene expression profile associated with the regulation of angiogenesis in endometrial cancer. Mol. Med. Rep., 2017, 16(3), 2547-2555.
[29]
Xia, H.; Jianxiang, C.; Shi, M.; Gao, H.; Karthik, S.; Pratap, S.V.; Ooi, L.L.; Hui, K.M. EDIL3 is a novel regulator of epithelial mesenchymal transition controlling early recurrence of hepatocellular carcinoma. J. Hepatol., 2015, 63(4), 863-873.
[30]
Grenda, A.; Budzyński, M.; Filip, A. Biogeneza cząsteczek mikrona oraz ich znaczenie w powstawaniu i przebiegu wybranych zaburzeń hematologicznych. Postepy Hig. Med. Dosw.(online)., 2013, 67, 174-185.
[31]
Betel, D.; Wilson, M.; Gabow, A.; Marks, D.S.; Sander, C. The microRNA.org resource, targets and expression. Nucleic Acids Res., 2008, 36(Database issue), D149-D153.
[32]
Cobb, L.P.; Siamakpour-Reihani, S.; Zhang, D.; Owzar, K.; Berchuck, A.; Bae-Jump, V.L.; Secord, A.A. Obesity is associated with altered angiogenic gene expression in endometrioid endometrial cancer. Gynecol. Oncol., 2018, 149(1), 177-178.
[33]
Szymkowiak, J. Otyłość jako rodzaj przewlekłego zapalenia. Wszechświat, 2011, 112(10), 264-272.
[34]
Lopes-Bastos, B.M.; Jiang, W.G.; Cai, J. Tumour-endothelial cell communications, important and indispensable mediators of tumour angiogenesis. Anticancer Res., 2016, 36(3), 1119-1126.
[35]
Zhang, R. Wei; Y.H., Zhao, C.Y.; Song, H.Y.; Shen, N.; Cui, X.; Gao, X.; Qi, Z.T.; Zhong, M.; Shen, W. EDIL3 depletion suppress epithelial-mesenchymal transition of lens epithelial cells via transforming growth factor β pathway. Int. J. Ophthalmol., 2018, 11(1), 18-24.
[36]
Vouk, K.; Smuc, T.; Guggenberger, C.; Ribič-Pucelj, M.; Sinkovec, J.; Husen, B.; Thole, H.; Houba, P.; Thaete, C.; Adamski, J.; Rižner, T.L. Novel estrogen-related genes and potential biomarkers of ovarian endometriosis identified by differential expression analysis. J. Steroid Biochem. Mol. Biol., 2011, 125(3-5), 231-224.
[37]
Jiang, S.H.; Wang, Y.; Yang, J.Y.; Li, J.; Feng, M.X.; Wang, Y.H.; Yang, X.M.; He, P.; Tian, G.A.; Zhang, X.X.; Li, Q.; Cao, X.Y.; Huo, Y.M.; Yang, M.W.; Fu, X.L.; Li, J.; Liu, D.J.; Dai, M.; Wen, S.Y.; Gu, J.R.; Hong, J.; Hua, R.; Zhang, Z.G. Sun. Y.W. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer. Oncotarget, 2016, 7(4), 4226-4240.
[38]
Jones, G.N.; Rooney, C.; Griffin, N.; Roudier, M.; Young, L.A.; Garcia-Trinidad, A.; Hughes, G.D.; Whiteaker, J.R.; Wilson, Z.; Odedra, R.; Zhao, L.; Ivey, R.G.; Howat, W.J.; Harrington, E.A.; Barrett, J.C.; Ramos-Montoya, A.; Lau, A.; Paulovich, A.G.; Cadogan, E.B.; Pierce, A.J. pRAD50, a novel and clinically applicable pharmacodynamic biomarker of both ATM and ATR inhibition identified using mass spectrometry and immunohistochemistry. Br. J. Cancer, 2018, 119(10), 1233-1243.
[39]
Seuma, J.; Bunch, J.; Cox, A.; McLeod, C.; Bell, J.; Murray, C. Combination of immunohistochemistry and laser ablation ICP mass spectrometry for imaging of cancer biomarkers. Proteomics, 2008, 8(18), 3775-3784.
[40]
Schwamborn, K.; Caprioli, R.M. Molecular imaging by mass spectrometry-looking beyond classical histology. Nat. Rev. Cancer, 2010, 10(9), 639-646.
[41]
Kaweewong, K.; Garnjanagoonchorn, W.; Jirapakkul, W.; Roytrakul, S. Solubilization and identification of hen eggshell membrane proteins during different times of chicken embryo development using the proteomic approach. Protein J., 2013, 32(4), 297-308.
[42]
Stamer, W.D.; Hoffman, E.A. Luthe,r J.M.; Hache,y D.L.; Schey, K.L. Protein profile of exosomes from trabecular meshwork cells. J. Proteomics, 2011, 74(6), 796-804.
[43]
Netea, M.G.; Balkwill, F.; Chonchol, M.; Cominelli, F.; Donath, M.Y.; Giamarellos-Bourboulis, E.J.; Golenbock, D.; Gresnigt, M.S.; Heneka, M.T.; Hoffman, H.M.; Hotchkiss, R.; Joosten, L.A.B.; Kastner, D.L.; Korte, M.; Latz, E.; Libby, P.; Mandrup-Poulsen, T.; Mantovani, A.; Mills, K.H.G.; Nowak, K.L.; O’Neill, L.A.; Pickkers, P.; van der Poll, T.; Ridker, P.M.; Schalkwijk, J.; Schwartz, D.A.; Siegmund, B.; Steer, C.J.; Tilg, H.; van der Meer, J.W.M.; van de Veerdonk, F.L.; Dinarello, C.A. A guiding map for inflammation. Nat. Immunol., 2017, 18(8), 826-831.
[44]
Yin, X.H.; Shi, M.; Wu, H.; Zhou, L.; Xu, B. Role of HAND2 gene and protein expression in endometrial carcinoma. Eur. J. Gynaecol. Oncol., 2017, 38(1), 95-101.
[45]
Opławski, M.; Dziobek, K.; Adwent, I.; Dąbruś, D.; Grabarek, B.; Zmarzły, N.; Plewka, A.; Boroń, D. Expression profile of endoglin in different grades of endometrial cancer. Curr. Pharm. Biotechnol., 2018, 19(12), 990-995.
[46]
Opławski, M.; Dziobek, K.; Grabarek, B.; Zmarzły, N.; Dąbruś, D.; Januszyk, P.; Brus, R.; Tomala, B.; Boroń, D. Expression of NRP-1 and NRP-2 in Endometrial Cancer. Curr. Pharm. Biotechnol., 2018, 20, 1-7.
